BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURG

NCT04478357 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Neurogenic Detrusor Overactivity

Interventions

DRUG: 4 mg Fesoterodine ER tablet from Zwickau
DRUG: 4 mg fesoterodine ER tablet from Freiburg
DRUG: 8 mg fesoterodine ER tablet from Zwickau
DRUG: 8 mg fesoterodine ER tablet from Freiburg

Sponsor

Pfizer